| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263
We investigated the biological activities of the natural and unnatural diastereoisomers of 5-formyltetrahydrofolate [(6S)- and (6R)-5-HCO-H4PteGlu, respectively, both 99.99% pure], using a human ileocecal carcinoma cell line (HCT-8). Optimal cell growth could be supported by (6S)-5-HCO-H4PteGlu at concentrations as low as 1 nM. (6R)-5-HCO-H4PteGlu did not support growth. Modulation of the in vitro cytotoxicity of 5-fluoro-2'-deoxyuridine (FdUrd) and intracellular (6R)-5,10-methylenetetrahydrofolates [(6R)-CH2H4PteGlun] pools by (6S)- and (6R)-5-HCO-H4PteGlu was determined with cells growing in 1 nM (6S)-5-HCO-H4PteGlu. For the control cells, the concentration of FdUrd inhibiting growth by 50% was 179 nM and the total (6R)-CH2H4PteGlun was 2.3 pmol/106 cells. When cells were treated with (6S)-5-HCO-H4PteGlu for 24 h, the 50% inhibition concentration of FdUrd decreased with increasing concentrations of (6S)-5-HCO-H4PteGlu, and reached a plateau of 36 nM when (6S)-5-HCO-H4PteGlu was
1 µM. The total (6R)-CH2H4PteGlun pools were augmented by (6S)-5-HCO-H4PteGlu dose dependently up to 6.8 pmol/106 cells at 1 µM (6S)-5-HCO-H4PteGlu. (6S)-5-HCO-H4PteGlu at 10 µM did not further increase the total (6R)-CH2H4PteGlun, but induced a marked shift in the polyglutamate chain length distribution, with an increase in tri- and tetra-, and a decrease in penta-, hexa-, and heptaglutamate. The down-shift of (6R)-CH2H4-PteGlun polyglutamate chain length observed after (6S)-5-HCO-H4PteGlu treatment did not impair the modulation of FdUrd cytotoxicity. Thus shorter chain (6R)-CH2H4PteGlun (n = 34) function as well as longer ones (n = 57). (6R)-5-HCO-H4PteGlu, at 200 µM, had no effect on the cytotoxicity of FdUrd, the total (6R)-CH2H4PteGlun level, or chain length distribution in the presence or absence of additional (6S)-5-HCO-H4PteGlu. These results suggest that the high plasma (6R)-5-HCO-H4PteGlu concentrations (up to 200 µM) achieved in patients following i.v. administration of high doses of (6R,S)-5-HCO-H4PteGlu probably do not have adverse effects on the modulation of antitumor activity of FdUrd or 5-fluorouracil. Since the optimal dose and schedule of (6S)-5-HCO-H4PteGlu for modulation of fluoropyrimidines may vary from one cell type to another, introducing high doses of (6R,S)-5-HCO-H4PteGlu in patients so that the plasma concentration of the natural isomer reaches 10 µM is still recommended.
1 Supported by Program Grant CA21071 and Cancer Center Core Grant CA16056 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at Department of Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263.
Received 1/22/91. Accepted 4/18/91.
This article has been cited by other articles:
![]() |
J. Jolivet, A. Dayan, M. Beauchemin, D. Chahla, A. Mamo, and R. Bertrand Biochemical and Molecular Studies of Human Methenyltetrahydrofolate Synthetase Oncologist, August 1, 1996; 1(4): 248 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, H. Qi, J. Korenberg, T. A. Garrow, Y.-J. Choi, and B. Shane Purification and Properties of Human Cytosolic Folylpoly-gamma -glutamate Synthetase and Organization, Localization, and Differential Splicing of Its Gene J. Biol. Chem., May 31, 1996; 271(22): 13077 - 13087. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Jolivet, A Dayan, M Beauchemin, D Chahla, A Mamo, and R Bertrand Biochemical and molecular studies of human methenyltetrahydrofolate synthetase Stem Cells, January 1, 1996; 14(1): 33 - 40. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |